Dr. B. Vijayalakshmi Ayyar earned her Bachelor’s degree in Microbiology and Master’s in Biotechnology from Barkatullah University, Bhopal, India. Dr. Ayyar earned her Ph.D. in Biotechnology from Biomedical Diagnostics Institute, Ireland. During the doctoral program, the majority of her research was focused applied research, where, she worked on developing and engineering novel antibody-based reagents for cardiovascular disease diagnosis. Subsequently, she did two Post-Doctoral Fellowships, one at the Biomedical Diagnostics Institute at Ireland, where, she worked on developing cancer diagnostics followed by another one at the Baylor College of Medicine, USA, where, a majority of her research was on the development of an effective synthetic vaccine against botulinum neurotoxins (BoNT). During her Post-doctoral fellowship at Baylor College of Medicine, she was also instrumental in a successfully completing a project on humanizing an anti-HLA antibody for the treatment of myasthenia gravis, an auto-immune disease. Currently, Dr. Ayyar works as a Staff Scientist at the Department of Molecular Virology and Microbiology, Baylor College of Medicine where she works on studying the pathogenesis of norovirus for developing norovirus vaccines and therapeutics. Dr. Ayyar has published numerous Research publications and Review articles which have earned several hundreds of citations and is also an active member of reviewer/editorial boards of different scientific journals.